Promising new finding for therapies to treat persistent seizures in epileptic patients

January 16, 2013, Los Angeles Biomedical Research Institute at Harbor
Photos depict NMDA receptors moving to the neuron surface during status epilepticus (SE), persistent seizures. The NMDA receptors are in red (NR1), and the cell surface marker is in green (synaptophysin). When they are at the same location (cell surface), the overlap of red and green becomes yellow. The existence of more yellow with SE suggests many more surface NMDA receptors, which can serve as targets for new medication. Credit: Dr. David E. Nayor

In a promising finding for epileptic patients suffering from persistent seizures known as status epilepticus, researchers reported today that new medication could help halt these devastating seizures. To do so, it would have to work directly to antagonize NMDA receptors, the predominant molecular device for controlling synaptic activity and memory function in the brain.

"Despite the development of new medications to prevent seizures, status epilepticus remains a life-threatening condition that can cause extensive brain damage in the patients that survive these persistent seizures," said David E. Naylor, MD, PhD, a lead researcher at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) and corresponding author of the new study. "Our research holds promise for the development of new therapies to treat this devastating condition because we have found a potential new for medical intervention that should bolster the current standard therapies to treat the acute seizures. It may also prevent the long-term adverse effects of persistent seizure activity on the brain."

The research, reported online in the Neurology of Disease journal, used animal models to assess cellular activity in the brain during persistent seizures. It found that the seemed to force the NMDA receptors from the interior to the surface of causing their activity to increase by approximately 38%.

"The increased presence of the NMDA receptors on the cell surface during these seizures may explain the successful use of NMDA antagonists – medication that inhibits the activity of the NMDA receptors in the brain – in the latter stages of a seizure, long after other medications have stopped working," said Dr. Naylor. "We concluded that medications that suppress the activity of the NMDA receptors, in conjunction with other medications, may be successful in stopping . Further research is, of course, needed."

Explore further: Surprising results from study of non-epileptic seizures

More information: www.sciencedirect.com/science/ … ii/S0969996113000065

Related Stories

Surprising results from study of non-epileptic seizures

December 2, 2012
A Loyola University Medical Center neurologist is reporting surprising results of a study of patients who experience both epileptic and non-epileptic seizures.

New drug target for Alzheimer's, stroke discovered

October 11, 2011
A tiny piece of a critical receptor that fuels the brain and without which sentient beings cannot live has been discovered by University at Buffalo scientists as a promising new drug target for Alzheimer's and other neurodegenerative ...

Recommended for you

In live brain function, researchers are finally seeing red

November 12, 2018
For years, green has been the most reliable hue for live brain imaging, but after using a new high-throughput screening method, researchers at the John B. Pierce Laboratory and the Yale School of Medicine, together with collaborators ...

Researchers identify the neural basis of threatening and aggressive behaviors in Drosophila

November 9, 2018
You can always tell when two guys are about to get into a fight. It starts with angry stares, puffed-out chests, arms tossed out to the side, and little, aggressive starts forward. Neuroscientists call the combination of ...

Multiple sclerosis: Accumulation of B cells triggers nervous system damage

November 9, 2018
B cells are important in helping the immune system fight pathogens. However, in the case of the neurological autoimmune disease multiple sclerosis (MS), they can damage nerve tissue. When particular control cells are missing, ...

Monkey gaze study shows dopamine's role in response inhibition

November 9, 2018
University of Tsukuba researchers report the importance of the brain's dopaminergic system for inhibiting already-planned actions. They trained monkeys to redirect their gaze toward targets presented on a screen, apart from ...

Navigating our thoughts: Fundamental principles of thinking

November 8, 2018
It is one of the most fundamental questions in neuroscience: How do humans think? Until recently, we seemed far from a conclusive answer. However, scientists from the Max Planck Institute for Human Cognitive and Brain Sciences ...

Study finds new mechanism for regulating sleep in fruit flies using an ingredient commonly found in energy drinks

November 8, 2018
Sleep is an essential behavioral state in animals ranging from invertebrates to humans. It is critical for immune function, stable metabolism, brain repair, learning and memory. Over the course of a lifetime, more than 30 ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.